Answer
Mar 06, 2026 - 11:22 AM
Molnupiravir is no longer recommended because studies have shown it is less effective at reducing severe illness and hospitalization from COVID-19 compared to other available treatments. Additionally, concerns have been raised about its potential to cause mutations in the virus. Therefore, health authorities now advise using alternative antiviral medications.
